Patents
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
01/2007
01/18/2007US20070015793 Synthesis of nojirimycins
01/18/2007US20070015791 4-[2-dimethylamino-1-(4-hydroxy-phenyl)-ethyl]-piperidin-4-ol; lower undesirable side-effects; treating irritable bowel syndrome, premature ejaculation and urinary incontinence
01/18/2007US20070015788 N-(3-Aryl-3-substitutedphenylpropyl) piperidines or 8-azabicyclo[3.2.1]octanes that are additionally substituted with an optionally fused 5-member N-heterocycle; the compounds are modulators of CCR5 receptor activity and are used in treating diseases such as rheumatoid arthritis
01/18/2007US20070015762 NPY Y5 antagonist
01/18/2007US20070015755 Novel compounds and compositions as protease inhibitors
01/18/2007CA2614691A1 Piperidine derivatives useful in the diagnostic and therapeutic treatment of diseases depending on renin activity
01/18/2007CA2612506A1 Methods of treatment using hydroquinone ansamycins
01/17/2007EP1742908A1 Non-nucleoside reverse transcriptase inhibitors
01/17/2007EP1742907A2 Certain chemical entities, compositions, and methods
01/17/2007EP1742905A2 Process of making alfa-aminooxyketone/ alfa-aminooxyaldehyde and alfa-hydroxyketone/ alfa-hydroxyaldehyde compounds and a process of making reaction products from cyclic alfa, beta-unsaturated ketone substrates and nitroso substrates
01/17/2007EP1742707A2 Treatment of cns disorders using cns target modulators
01/17/2007EP1345900B1 Guanidine and amidine derivatives as factor xa inhibitors
01/17/2007CN1898212A Analogs of benzoquinone-containing ansamycins for the treatment of cancer
01/17/2007CN1898206A Allosteric modulators of metabotropic glutamate receptors
01/17/2007CN1897946A 1- 2' (1, 4'-biperidin-1'-yl)-1- (phenyl) -ethyl cyclohexanol derivatives as monoamine reuptake modulators for the treatment of visomotor symptoms
01/16/2007US7164027 Aralkyl ester soft drugs
01/16/2007US7164025 Manufacture of single isomer methylphenidate
01/16/2007US7163958 Compositions comprising nitrosated NSAID and compound that donates, transfers or releases nitric oxide, or stimulates endogenous synthesis of nitric oxide; treatment of inflammation, pain, fever, gastrointestinal disorders
01/16/2007US7163937 Cyclic derivatives as modulators of chemokine receptor activity
01/16/2007CA2257234C Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
01/16/2007CA2201779C The manufacture of levobupivacaine and analogues thereof from l-lysine
01/11/2007WO2007005603A2 Novel hydroxamic acid-containing amino acid derivatives
01/11/2007WO2007003965A1 Substituted cyclohexyl derivatives as nk-3 receptor antagonists
01/11/2007WO2007003964A1 G-protein coupled receptor agonists
01/11/2007WO2007003962A2 Gpcr agonists
01/11/2007WO2007003934A2 17beta-hydr0xyster0id dehydrogenase type 3 (17beta-hsd3 ) inhibitors
01/11/2007WO2006117669B1 Amide resorcinol compounds
01/11/2007WO2006102535A3 Sulfonyl containing compounds as cysteine protease inhibitors
01/11/2007US20070010677 Process for production of piperidine derivatives
01/11/2007US20070010669 Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
01/11/2007US20070010558 Opioid receptor antagonists
01/11/2007US20070010511 Organic compounds
01/11/2007US20070010509 Cycloamine ccr5 receptor antagonists
01/11/2007US20070010457 Caspase inhibitors and uses thereof
01/11/2007CA2613236A1 G-protein coupled receptor agonists
01/11/2007CA2613235A1 Gpcr agonists
01/11/2007CA2611867A1 Substituted cyclohexyl derivatives as nk-3 receptor antagonists
01/10/2007EP1741702A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof
01/10/2007EP1741701A1 Processes for producing 1-benzyl-4-¬(5,6-dimethoxy-1­indanon)-2-yl|methylpiperidine and hydrochloride thereof
01/10/2007EP1741428A2 Cell adhesion inhibitors
01/10/2007EP1740577A2 Selected cgrp antagonists, methods for the production thereof, and use thereof as medicaments
01/10/2007EP1740575A2 Pyrrolidine derivatives useful as bace inhibitors
01/10/2007EP1740573A1 Amides as bace inhibitors
01/10/2007EP1740570A2 Novel gamma secretase inhibitors
01/10/2007EP1740565A2 Arylphenylamino-, arylphenylamide-, and arylphenylether-sufide derivatives
01/10/2007EP1740561A2 Arylphenylamino-and arylphenylether-sulfide derivatives, useful for the treatment of inflammatory and immune diseases, and pharmaceutical compositions containing them
01/10/2007EP1740553A1 Aryl glycinamide derivatives and their use as nk1 antagonists and serotonin reuptake inhibithors
01/10/2007EP1740540A1 Phenyl acetamides
01/10/2007EP1740537A2 A process for the preparation of 2,2-disubstituted pyrroles
01/10/2007EP1740535A1 Thio-substituted methanesulfinyl derivatives
01/10/2007EP1353905B1 Piperidine/piperazine-type inhibitors of p38 kinase
01/10/2007EP1066259B1 Biocidal benzylbiphenyl derivatives
01/10/2007CN1894214A New 5,6-dihydropyrin-2-one compounds useful as inhibitors of thrombin
01/10/2007CN1894206A N-substituted-N-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
01/09/2007US7161006 Enzyme inhibitors for treatment of Alzhemer's Disease
01/09/2007US7160966 Polymerizable composition with free radicals and by controlling polymerization
01/09/2007US7160907 Pleuromutilin derivatives
01/09/2007US7160905 Hydroxyethylene compounds with Asp2 inhibitory activity
01/09/2007US7160903 Sulfonylaminocarboxylic acids
01/09/2007US7160887 Aromatic amine derivatives, their production and use
01/09/2007US7160886 For therapy and prophylaxis of obesity, diabetes, sexual dysfunction, including erectile dysfunction and female sexual dysfunction
01/09/2007CA2338276C Fkbp inhibitors
01/09/2007CA2260790C Deoxynojirimycin derivatives and their uses as glucosylceramidase inhibitors
01/09/2007CA2201780C Racemisation of precursors to levobupivacaine and analogues thereof
01/09/2007CA2200490C Racemisation and asymmetric transformation processes used in the manufacture of levobupivacaine and analogues thereof
01/09/2007CA2159988C Novel deoxygalactonojirimycin derivatives
01/04/2007WO2007002884A2 4-fluoro-piperidine t-type calcium channel antagonists
01/04/2007WO2007000001A2 Pleuromutilin salts with salicylic acid, azelaic acid, sebacic acid and diclofenac
01/04/2007WO2006096769A3 Use of alpha-glucosidase inhibitors to treat alphavirus infections
01/04/2007WO2005048922A3 Sulfonylaminovalerolactams and derivatives thereof as factor xa inhibitors
01/04/2007US20070004922 for preparing aldehydes or ketones using an alkali metal hypochlorite or an alkaline earth metal hypochlorite in the presence of a ruthenium catalyst
01/04/2007US20070004783 Crystalline forms of amlodipine maleate
01/04/2007US20070004776 2-amino-3-[4-(4-hydroxycarbamoylphenoxy)-phenyl]-propionic acids, esters and salts; antiinflammatory, antidiabetic, anticholesterol and hypoglycemic agents; metabolic disorders; inhibitors of TNF-alpha, IL-1 beta, IL-6, and IL-12
01/04/2007US20070004742 Arylpiperazinyl compounds
01/04/2007US20070004726 4-[2-(3-tert-Butyl-4-diethylaminophenyl)-2-hydroxyiminoethoxy]benzoic acid; modulates nuclear retinoic acid receptors; suited for formulation into pharmaceutical compositions useful in human or veterinary medicine, or into cosmetic compositions
01/04/2007CA2611639A1 4-fluoro-piperidine t-type calcium channel antagonists
01/04/2007CA2611153A1 3-fluoro-piperidine t-type calcium channel antagonists
01/03/2007EP1737849A1 Compounds having morpholinyl and piperidinyl groups for use as glyt1 inhibitors
01/03/2007EP1737822A1 N-'4-4(4-morpholinyl) phenyl!-'(4-piperidinyl) methyl! carboxamide derivatives and their use as glycine transporter inhibitors
01/03/2007EP1737815A1 Thio-substituted biaryl-methanesulfinyl derivatives
01/03/2007EP1562925B1 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
01/03/2007EP1423381B1 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
01/03/2007CN1890217A N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein B
01/03/2007CN1890216A Carboxamide derivatives
01/03/2007CN1890208A Opioid receptor antagonists
01/03/2007CN1887866A Prepn of ebastine
01/03/2007CN1293065C Piperazinyl- or piperidinylamine-sulfamic acid amides as inhibitors of steroid sulfatase
01/03/2007CN1293055C Piperidine derivative crystal, midbody for preparation and preparing method
01/03/2007CN1292744C Carboxylic acid derivs. that inhibit binding of integrins to their receptors
01/02/2007US7157585 An aromatic alkylamino compound containing a lipophilic group useful as antithrombotic agent and for use in the treatment of mast cell mediated diseases such as asthma and other allergic and inflammatory conditions
01/02/2007US7157490 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
01/02/2007US7157471 Haloalkyl- and piperidine-substituted benzimidazole-derivatives
01/02/2007US7157470 For use as anticoagulant agents for therapy of thromboembolic disorders
01/02/2007US7157454 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
01/02/2007US7157430 (Substituted)acyl dipeptidyl inhibitors of the ICE/CED-3 family of cysteine proteases
01/02/2007CA2274464C Ketobenzamides as calpain inhibitors
12/2006
12/28/2006WO2006138218A1 Biphenyl compounds useful as muscarinic receptor antagonists
12/28/2006WO2006136714A1 Novel compounds of the family of iminosugars, uses thereof for treating lysosomal diseases, and method for preparing same
12/28/2006WO2006136305A1 SUBSTITUTED PYRR0LIDIN-2-0NES , PIPERIDIN-2-0NES AND ISOTHIAZOLIDINE-1, 1-DIOXIDES, THEIR USE AS KVl .5 POTASSIUM CHANNEL BLOCKERS AND PHARMACEUTICAL PREPARATIONS COMPRISING THEM
12/28/2006WO2006136087A1 Preparation method of pregabalin and its intermediate and the said intermediate